Home/Filings/4/0001193125-25-288306
4//SEC Filing

PORTNOY DAVID 4

Accession 0001193125-25-288306

CIK 0000862692other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 5:11 PM ET

Size

23.9 KB

Accession

0001193125-25-288306

Insider Transaction Report

Form 4
Period: 2025-11-17
PORTNOY DAVID
DirectorChairman, Co-CEO10% Owner
Transactions
  • Award

    Common Stock

    2025-11-17$4.00/sh+1,429$5,716843,979 total
  • Award

    Common Stock

    2025-11-18$4.09/sh+640$2,618844,619 total
  • Award

    Common Stock

    2025-11-19$4.08/sh+1,921$7,838846,540 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    164,182
  • Common Stock

    (indirect: By IRA)
    268,878
  • Common Stock

    (indirect: As Custodian for son)
    11,398
  • Common Stock

    (indirect: As Custodian for son)
    10,939
  • Common Stock

    (indirect: By Spouse)
    107,403
  • Common Stock

    (indirect: As Custodian for son)
    11,537
  • Common Stock

    (indirect: By Corporation)
    57,306
  • Stock Option

    Exercise: $4.77From: 2023-01-03Exp: 2028-01-03Common Stock (50,000 underlying)
    50,000
  • Stock Option

    Exercise: $7.53From: 2019-08-30Exp: 2029-08-30Common stock (26,243 underlying)
    26,243
  • Stock Option

    Exercise: $6.47From: 2023-12-22Exp: 2028-12-22Common Stock (50,000 underlying)
    50,000
  • Stock Option

    Exercise: $8.08From: 2025-01-21Exp: 2030-01-21Common Stock (50,000 underlying)
    50,000
  • Common Stock

    (indirect: By Corporation)
    161,833
  • Stock Option

    Exercise: $12.27From: 2021-12-22Exp: 2028-12-22Common Stock (280,000 underlying)
    280,000
  • Stock Option

    Exercise: $4.30From: 2022-12-23Exp: 2027-12-23Common Stock (50,000 underlying)
    50,000
  • Common Stock

    (indirect: By LLC)
    59,027
  • Stock Option

    Exercise: $7.28From: 2019-12-20Exp: 2029-12-20Common Stock (23,636 underlying)
    23,636
Footnotes (8)
  • [F1]The price reported is a weighted average price of $4.08. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
  • [F2]Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary.
  • [F3]Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
  • [F4]Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
  • [F5]Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
  • [F6]8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
  • [F7]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
  • [F8]Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.

Documents

1 file

Issuer

CRYO CELL INTERNATIONAL INC

CIK 0000862692

Entity typeother

Related Parties

1
  • filerCIK 0001315416

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:11 PM ET
Size
23.9 KB